Epigenome editing technologies for discovery and medicine

SR McCutcheon, D Rohm, N Iglesias… - Nature …, 2024 - nature.com
Epigenome editing has rapidly evolved in recent years, with diverse applications that
include elucidating gene regulation mechanisms, annotating coding and noncoding …

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

S Ding, J Liu, X Han, M Tang - International Journal of Molecular Sciences, 2023 - mdpi.com
The Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated
protein 9 (CRISPR/Cas9) system, an RNA-based adaptive immune system found in bacteria …

Genome-scale pan-cancer interrogation of lncRNA dependencies using CasRx

JJ Montero, R Trozzo, M Sugden, R Öllinger, A Belka… - Nature …, 2024 - nature.com
Although long noncoding RNAs (lncRNAs) dominate the transcriptome, their functions are
largely unexplored. The extensive overlap of lncRNAs with coding and regulatory …

[HTML][HTML] Genome-Wide CRISPR Screen Identifies Genes Involved in Metastasis of Pancreatic Ductal Adenocarcinoma

R Oktriani, AC Pirona, L Kalmár, AS Rahadian, B Miao… - Cancers, 2024 - mdpi.com
Abstract Background/Objectives: Early and aggressive metastasis is a major feature of
pancreatic ductal adenocarcinoma. Understanding the processes underlying metastasis is …

[HTML][HTML] Advancements in CRISPR screens for the development of cancer immunotherapy strategies

YR Li, Z Lyu, Y Tian, Y Fang, Y Zhu, Y Chen… - Molecular Therapy …, 2023 - cell.com
CRISPR screen technology enables systematic and scalable interrogation of gene function
by using the CRISPR-Cas9 system to perturb gene expression. In the field of cancer …

Application of CRISPR for in vivo mouse cancer studies

MK Thomsen - Cancers, 2022 - mdpi.com
Simple Summary Clustered regularly interspaced short palindromic repeats (CRISPR) were
discovered in prokaryotes, and the technology can also be used to edit the genome in …

[PDF][PDF] CRISPR screening by AAV episome-sequencing (CrAAVe-seq) is a highly scalable cell type-specific in vivo screening platform

B Ramani, IVL Rose, N Teyssier, A Pan… - bioRxiv, 2024 - biorxiv.org
CRISPR-based genetic screening directly in mammalian tissues in vivo is challenging due
to the need for scalable, cell-type selective delivery and recovery of guide RNA libraries. We …

Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells

M Liu, Z Zhao, C Wang, S Sang, Y Cui, C Lv, X Yang… - Cancer Letters, 2024 - Elsevier
Genetic interactions (GIs) refer to two altered genes having a combined effect that is not
seen individually. They play a crucial role in influencing drug efficacy. We utilized CGIdb 2.0 …

In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution

A Fischer, R Lersch, N de Andrade Krätzig, A Strong… - Cell Genomics, 2023 - cell.com
In contrast to mono-or biallelic loss of tumor-suppressor function, effects of discrete gene
dysregulations, as caused by non-coding (epi) genome alterations, are poorly understood …

[HTML][HTML] The double-edge sword of CRISPR application for in vivo studies

MK Thomsen - Oncotarget, 2023 - ncbi.nlm.nih.gov
A decade ago, the hallmark paper by Platt et al. was published on the in vivo application of
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) to generate cancer in …